SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Stock Price Chart Interactive Chart >
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $128.29 | 52-week high | $174.79 |
| Prev. close | $128.72 | 52-week low | $89.45 |
| Day low | $125.90 | Volume | 7,160,286 |
| Day high | $130.14 | Avg. volume | 6,605,226 |
| 50-day MA | $143.60 | Dividend yield | 0.25% |
| 200-day MA | $129.97 |
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 6.85B |
| Net Asset Value (NAV) | $128.56 |
| Options? | Yes |
| Total Holdings | 195 |
XBI Top Holdings
| Symbol | Company | % of Total |
| UTHR | United Therapeutics Corp | 0.91% |
| VCEL | Vericel Corp | 0.89% |
| MRNA | Moderna Inc | 0.88% |
| DVAX | DYNAVAX TECHNO | 0.81% |
| NVAX | Novavax Inc | 0.79% |
| AMGN | Amgen Inc. | 0.79% |
| CDNA | CareDx Inc | 0.78% |
| DCPH | DCPHRA PHRMCTC | 0.77% |
| GILD | GILEAD SCI | 0.77% |
| CYTK | Cytokinetics Incorporated | 0.77% |
XBI Price Returns
| 1-mo | -11.54% |
| 3-mo | -16.74% |
| 6-mo | 9.77% |
| 1-year | 35.42% |
| 3-year | 44.83% |
| 5-year | 125.49% |
| YTD | -8.85% |
| 2020 | 48.33% |
| 2019 | 32.56% |
| 2018 | -15.28% |
| 2017 | 43.77% |
| 2016 | -15.45% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!